一分钟看懂
这是一项关于非小细胞肺癌的III 期研究，登记的药物或干预包括PF-08634404；Pembrolizumab；Chemotherapy Regimen 1；Chemotherapy Regimen 2，当前状态为招募中。登记地点显示中国合肥、北京、重庆、福州等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
PF-08634404；Pembrolizumab；Chemotherapy Regimen 1；Chemotherapy Regimen 2 · III 期
登记条件中文摘要
登记的基本范围为不限性别，年龄18 岁；另列出7项专业入选条件，需结合英文原文并由研究团队确认。
登记记录列出8项主要排除条件，具体医学含义需结合英文原文并由研究团队确认。
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Anhui Provincial Cancer Hospital · 合肥
- Second Affiliated hospital of Anhui Medical University · 合肥
- Beijing Cancer hospital · 北京
- Beijing Peking Union Medical College Hospital · 北京
- The First Affiliated Hospital of Chongqing Medical University · 重庆
- Chongqing University Cancer Hospital · 重庆
- Fujian Cancer Hospital · 福州
- Southern Medical University Nanfang Hospital · 广州
- Huizhou Central People's Hospital · 惠州
- Jiangmen Central Hospital · 江门
- Guangxi Medical University Affiliated Tumor Hospital · 南宁
- The First Affiliated Hospital of Henan University of Science &Technology · 洛阳
- Henan Cancer Hospital · 郑州
- Union Hospital Tongji Medical College Huazhong University of Science and Technology · 武汉
- Xiangyang Central Hospital · 襄阳
- Xiangya Hospital Central South University · 长沙
- The Second Xiangya Hospital of Central South University · 长沙
- Jiangsu Province Hospital · 南京
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School · 南京
- Northern Jiangsu People's Hospital · 扬州
- The Second Affiliated Hospital of Nanchang University · 南昌
- The First Affiliated Hospital of Nanchang University · 南昌
- The First Hospital of Jilin University · 长春
- Jinan Central Hospital · 济南
- LinYi Cancer Hospital · 临沂
- Fudan University Shanghai Cancer Center · 上海
- Shanxi Cancer Hospital · 太原
- Sichuan Cancer hospital · 成都
- The first Affiliated Hospital, Zhejiang University School of Medicine · 杭州
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine · 杭州
- Taizhou Hospital of Zhejiang Province · 台州
- The First Affiliated Hospital of Wenzhou Medical University · 温州
- Beijing Chest Hospital, Capital Medical University · 北京
- Shanghai Chest Hospital · 上海
- Shanghai East Hospital · 上海
- Hubei Cancer Hospital · 武汉
公开的入选条件
- * 18 years of age or older at screening.
- * Have pathologically confirmed locally advanced (Stage IIIB/IIIC) or metastatic (Stage IV)squamous or non-squamous NSCLC and not be a candidate for complete surgical resection and curative concurrent/sequential chemoradiotherapy (according to the 9th edition
- * Have tumor tissue available, either paraffin block or slides from a core, excisional or fine needle biopsy
- * PD-L1 status available based on local testing results
- * Measurable disease based on RECIST v1.1 per investigator.
- * Eastern Cooperative Oncology Group performance status (ECOG) score of 0 or 1
- * Expected survival ≥12 weeks
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT07222566；登记信息更新于 2026-09-25。